Bio-Rad Laboratories - 45 Year Stock Price History | BIO

Historical daily share price chart and data for Bio-Rad Laboratories since 1980 adjusted for splits and dividends. The latest closing stock price for Bio-Rad Laboratories as of June 12, 2025 is 232.42.
  • The all-time high Bio-Rad Laboratories stock closing price was 825.77 on September 02, 2021.
  • The Bio-Rad Laboratories 52-week high stock price is 387.99, which is 66.9% above the current share price.
  • The Bio-Rad Laboratories 52-week low stock price is 211.43, which is 9% below the current share price.
  • The average Bio-Rad Laboratories stock price for the last 52 weeks is 301.14.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Bio-Rad Laboratories Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 271.2203 326.1600 367.0000 216.5600 232.4200 -29.25%
2024 319.1788 327.9900 374.2800 263.9700 328.5100 1.74%
2023 393.2294 422.4300 503.0000 269.3700 322.8900 -23.21%
2022 505.9841 735.4200 735.4200 351.7100 420.4900 -44.35%
2021 675.8090 575.2600 825.7700 547.0100 755.5700 29.61%
2020 472.1816 372.1600 643.4500 320.0100 582.9400 57.54%
2019 312.5641 228.0800 374.2000 224.3000 370.0300 59.34%
2018 277.5328 241.4200 326.1500 220.1000 232.2200 -2.70%
2017 219.5758 182.9100 271.3000 182.9100 238.6700 30.94%
2016 149.1690 136.1900 183.4600 123.9300 182.2800 31.46%
2015 137.5260 120.3500 151.9300 113.7700 138.6600 15.01%
2014 120.8765 122.6500 133.7300 106.4800 120.5600 -2.47%
2013 118.6682 107.4600 126.0000 107.4600 123.6100 17.67%
2012 102.7218 98.0800 114.2500 92.3000 105.0500 9.38%
2011 108.0200 105.3200 126.3400 87.5400 96.0400 -7.52%
2010 94.7088 97.8700 113.6300 81.5000 103.8500 7.66%
2009 78.5782 74.4700 100.4600 53.1000 96.4600 28.08%
2008 87.1254 99.9700 108.1000 61.5200 75.3100 -27.32%
2007 82.9541 82.2200 107.5700 67.6700 103.6200 25.57%
2006 68.9380 65.4500 84.0100 57.2500 82.5200 26.10%
2005 55.5089 57.1700 66.9000 47.0600 65.4400 14.07%
2004 55.2252 58.4100 61.9000 50.0100 57.3700 -0.52%
2003 48.0377 38.2100 62.1500 33.4000 57.6700 49.02%
2002 39.7467 30.9000 50.5100 28.1250 38.7000 22.27%
2001 23.7924 16.0500 32.5250 15.0750 31.6500 99.06%
2000 12.9793 11.3125 16.7450 10.6250 15.9000 36.04%
1999 12.2612 10.3125 14.5000 9.4375 11.6875 11.31%
1998 13.1470 13.0625 16.8750 9.8750 10.5000 -19.62%
1997 13.5673 15.1875 16.3750 11.8125 13.0625 -12.92%
1996 14.6823 14.2083 18.3125 12.1250 15.0000 5.88%
1995 11.3629 9.1250 14.1667 8.4583 14.1667 53.15%
1994 6.4239 3.5000 9.6250 3.5000 9.2500 177.50%
1993 4.7749 5.7083 5.9167 3.3333 3.3333 -41.61%
1992 6.1821 6.4167 7.1250 5.3750 5.7083 -13.29%
1991 7.0525 6.0833 9.1667 5.5417 6.5833 6.76%
1990 5.8093 5.4167 7.6667 4.2083 6.1667 15.63%
1989 5.6551 5.7083 6.5417 4.7500 5.3333 -5.88%
1988 6.3804 5.2500 7.7083 4.9167 5.6667 11.48%
1987 7.6194 5.8750 10.6667 3.7500 5.0833 -11.59%
1986 5.9523 5.0556 7.6389 4.5556 5.7500 13.74%
1985 3.2332 2.1296 5.3056 2.1296 5.0556 137.40%
1984 2.2030 2.5000 2.5185 2.0741 2.1296 -14.82%
1983 2.3316 1.3519 2.8704 1.3519 2.5000 87.50%
1982 1.3125 1.5370 1.6111 0.8704 1.3333 -7.69%
1981 2.4658 2.9815 3.6667 1.2963 1.4444 -51.25%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.264B $2.567B
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $235.365B 28.30
Boston Scientific (BSX) United States $147.057B 36.81
Stryker (SYK) United States $145.454B 30.41
EssilorLuxottica (ESLOY) France $130.907B 0.00
Medtronic (MDT) Ireland $112.941B 16.01
Lonza Group Ag (LZAGY) Switzerland $50.659B 0.00
Haleon (HLN) United Kingdom $49.106B 27.97
ResMed (RMD) United States $36.856B 27.68
Agilent Technologies (A) United States $34.008B 22.17
GE HealthCare Technologies (GEHC) United States $33.609B 15.96
Terumo (TRUMY) Japan $26.946B 35.00
Koninklijke Philips (PHG) Netherlands $22.201B 15.96
Insulet (PODD) United States $21.270B 83.49
Zimmer Biomet Holdings (ZBH) United States $18.645B 11.98
Baxter (BAX) United States $16.114B 12.03
Smith & Nephew SNATS (SNN) United Kingdom $13.196B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Demant (WILYY) Denmark $8.854B 0.00
Lantheus Holdings (LNTH) United States $5.587B 14.09
Prestige Consumer Healthcare (PBH) United States $4.206B 18.79
Perrigo (PRGO) Ireland $3.763B 9.54
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.435B 15.65
ICU Medical (ICUI) United States $3.309B 24.40
Envista Holdings (NVST) United States $3.259B 27.08
GN Store Nord (GNNDY) Denmark $2.362B 19.57
QuidelOrtho (QDEL) United States $2.094B 14.40
LeMaitre Vascular (LMAT) United States $1.878B 41.99
AtriCure (ATRC) United States $1.635B 0.00
Acuren (TIC) United States $1.305B 0.00
Neogen (NEOG) United States $1.238B 15.85
AdaptHealth (AHCO) United States $1.181B 11.99
BioLife Solutions (BLFS) United States $1.128B 0.00
Green Thumb Industries (GTBIF) United States $1.075B 24.19
Kestra Medical Technologies (KMTS) United States $1.001B 0.00
Phibro Animal Health (PAHC) United States $0.989B 12.64
InMode (INMD) Israel $0.903B 9.10
Evolus (EOLS) United States $0.660B 0.00
CeriBell (CBLL) United States $0.642B 0.00
Owens & Minor (OMI) United States $0.606B 5.03
Capricor Therapeutics (CAPR) United States $0.600B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.581B 0.00
Curaleaf Holdings (CURLF) Canada $0.554B 0.00
Valneva SE (VALN) France $0.534B 0.00
Tilray Brands (TLRY) Canada $0.429B 0.00
Surmodics (SRDX) United States $0.415B 0.00
VAREX IMAGING (VREX) United States $0.359B 13.21
SNDL (SNDL) Canada $0.349B 0.00
Aurora Cannabis (ACB) Canada $0.340B 60.40
Canopy Growth (CGC) Canada $0.289B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.283B 0.00
Cerus (CERS) United States $0.271B 0.00
Sanuwave Health (SNWV) United States $0.268B 0.00
Viemed Healthcare (VMD) United States $0.267B 22.50
ZimVie (ZIMV) United States $0.265B 12.06
Cresco Labs (CRLBF) United States $0.261B 0.00
Quanterix (QTRX) United States $0.259B 0.00
Sanara MedTech (SMTI) United States $0.257B 0.00
Brainsway (BWAY) Israel $0.222B 58.65
Biote (BTMD) United States $0.220B 6.18
OraSure Technologies (OSUR) United States $0.218B 0.00
Omeros (OMER) United States $0.212B 0.00
TriSalus Life Sciences (TLSI) United States $0.199B 0.00
Organigram Global (OGI) Canada $0.197B 0.00
High Tide (HITI) Canada $0.190B 0.00
Utah Medical Products (UTMD) United States $0.185B 15.09
Verano Holdings (VRNOF) United States $0.183B 0.00
Exagen (XGN) United States $0.155B 0.00
Vireo Growth (VREOF) United States $0.141B 0.00
FitLife Brands (FTLF) United States $0.130B 16.05
Jin Medical (ZJYL) China $0.108B 0.00
MacroGenics (MGNX) United States $0.108B 0.00
Veru (VERU) United States $0.099B 0.00
Quipt Home Medical (QIPT) United States $0.092B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Fonar (FONR) United States $0.090B 11.61
TerrAscend (TSNDF) Canada $0.078B 0.00
Agape ATP (ATPC) $0.078B 0.00
InterCure (INCR) Israel $0.071B 0.00
Cytosorbents (CTSO) United States $0.068B 0.00
Apyx Medical (APYX) United States $0.067B 0.00
Zynex (ZYXI) United States $0.062B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.057B 0.00
Modular Medical (MODD) United States $0.047B 0.00
Nephros (NEPH) United States $0.040B 54.21
United-Guardian (UG) United States $0.038B 13.18
Rockwell Medical (RMTI) United States $0.034B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Cellectar Biosciences (CLRB) United States $0.020B 0.00
Safety Shot (SHOT) United States $0.019B 0.00
Flora Growth (FLGC) United States $0.018B 0.00
INLIF (INLF) $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00